Clinical research organization India
clinical trials india Welcome

Your success. That’s our commitment at Excel Life Sciences. Everything we do is built around leveraging our expertise and passion to ensure that your clinical trials are successful. As the leading Trial Management Organization in India and through our trusted partnerships worldwide, we have the capabilities and bandwidth to take on any project large or small. And with offices and executive leadership based in the United States, you can be sure that we’re available when you are. Excel Life Sciences mixes a customized consultative approach with industry-leading experience and know-how to get results. Specifically our team’s experience includes:

  • 280 years combined experience in Clinical Medicine, Pharmaceutical Medicine and Biometrics
  • 50 years of regulatory experience and top USA and India regulatory executive’s on the ELS advisory board 
  • 350 successfully conducted clinical trials at over 1000 sites 
  • 135 IND approvals & 20+ NDA approvals in US, Europe & Asia
clinical trials india What's New at ELS

Excel Life Sciences Continues Successful Management of Clinical Trials in India as Regulators work to Improve Review Process

Excel Life Sciences President and Chief Medical Officer, Dr. Vijai Kumar, is featured in a just released story on the evolving clinical research landscape in India.  The article which appears in the web-based publication, eCliniqua, discusses some of the ongoing changes underway to create a more robust, efficient and predictable regulatory review process in India for clinical trials. Dr. Kumar shares information on the approach Excel Life Sciences takes to ensure timely regulatory approval for its clients global clinical trials. The company, with a unique operating model involving deployment of its own onsite clinical research coordinators to each site, prides itself on running ethical trials and delivering data quality and data integrity to its clients. Please click here to read the full article

 

Drugs To Watch: Potential Blockbusters Of 2014

Once a Notorious Short Seller, Now Sees A Future In Biotech

Albany Molecular Research, Inc. (AMRI) Shutters New York Research Center, Cuts 45 Jobs

Is Your Kitchen Making You Sick? Study

Discovered—Scientists Unravel Mystery Of How Sperm Recognizes Eggs, Wellcome Trust Sanger Institute Study

One Of A Kind Trial To Test 14 AstraZeneca PLC, Pfizer Inc. Drugs At The Same Time

San Diego's Vital Therapies, Inc. (VTI) Prices $54 Million IPO

Mom's Weight Linked To Stillbirth, Infant Death Risks, Imperial College London Study

Antibiotics Increase Growth In Undernourished Kids, McGill University Study

Lack Of Emotion And Interest May Signal Your Brain Is Shrinking, National Institutes of Health (NIH) Study

Feminine Girls, Masculine Boys Have Higher Cancer Risk, Harvard School of Public Health Study

Atypical Brain Connectivity Associated With Autism Spectrum Disorder, San Diego State University Study

GlaxoSmithKline Investigating Bribery Claims In Jordan And Lebanon

Obesity Can Amplify Bone And Muscle Loss, Florida State University Study

AstraZeneca PLC Opens Vast Library To Researchers But Gets First Dibs On New Drugs

Cancer Drugs Block Dementia-Linked Brain Inflammation, University of California, Irvine Study

Nora Therapeutics Announces $18 Million Series B Financing

SI Group Scoops Up Albemarle Corporation's Antioxidants, Ibuprofen And Propofol Businesses For Undisclosed Amount

Astellas Pharma US Makes $7.3 Million Deal With U.S. Department Of Justice

Startup Launches With $20 Million In Pocket

A Second Chance At Employment For Pennsylvania Life Sciences Workers

Stolen Roche Cancer Drug Found On Market

Lucky Drug Made Pharmacyclics, Inc.' A Billionaire—Can He Do It Again?

Antidepressants Use During Pregnancy Tied To Autism In Boys, University of California, Davis (UCD) And Johns Hopkins University Study

Boehringer Ingelheim Corporation Rethinks Hepatitis Business, Braces For A Rough 2014

Sleep Apnea May Boost Risk Of Cancer, University of Sydney Study

Viagra Ice Cream: New Flavor Contains Sildenafil Citrate

San Diego Accelerator Chooses 4 Startups To Be Guinea Pigs

Kids Misbehave Within 10 Minutes Of Spanking, Study

Exercise, Mental Development Linked Genetically? University of Missouri Study

Novartis AG Thinks Twice About RNAi Development, Slims Down R&D Group In Boston

Novartis AG To Lay Off 215 NJ Support Staff Employees

Even Casual Pot Smoking Can Change Your Brain, Northwestern University Feinberg School of Medicine Study

Boston-Based EPIRUS Biopharmaceuticals Reels In $36 Million Series B, Will Merge With Zalicus Inc. In All-Stock Deal

Baxter International, Inc. Drug BAX 111 Treats 100 Percent Of Bleeding Episodes In Small Phase 3 Trial

Obesity: Are Lipids Hard Drugs For The Brain? Study

Sleep Apnea May Up Osteoporosis Risk, Study

Novartis AG Overtakes Pfizer Inc. As Top Drug Company

Limiting A Certain Protein In The Brain Reverses Alzheimer's Symptoms In Mice, Massachusetts Institute of Technology (MIT) Study

Anti-Aging Secret: Younger Skin Through Exercise, McMaster University Study

The Truth: Why Pharma's Leaders Aren't Yet Capable

Wilson Therapeutics Bags $40 Million To Advance Late Stage Development Program For Wilson's Disease

How Mothers Help Children Explore Right And Wrong, Concordia University Study

Wake Forest University Baptist Medical Center Study Examines Vitamin D Deficiency And Cognition Relationship

BioAlliance Pharma And TopoTarget A/S To Merge To Form Orphan Oncology Powerhouse

Reckitt Benckiser Plc Leans Towards Pharmaceuticals Biz Spin-Off

OxThera, Inc. Receives SEK 70 Million Financing To Continue Its Key Clinical Programs

Nexvet Announces $31.5 Million Financing

Iconic Therapeutics, Inc. Nabs $20 Million For Wet AMD Program

Boehringer Ingelheim Corporation To Open Trial Data Back To 1998 In Bid To Improve Transparency Efforts

Novartis AG, Weighing $1.3 Billion Offer For ThromboGenics NV

NeoStem, Inc. To Buy Californian Peer For $124 Million+

New Jersey's PanOptica, Inc. Reels In $45 Million To Fund Development Of Wet AMD Eye Med

Bay Area's Igenica, Inc. Follows Genentech Into Antibody-Linked Cancer Drugs

Daytime Napping May Lead to An Early Death, Cambridge University Study

Chinese Herb As Effective As Arthritis Pain Drug, /i> Reveals

Eating Too Much Meat Tied To Higher Diabetes Risk, Harvard School of Public Health Study

Career Advice For Future Biotech Leaders

Lower Salt Intake Likely To Have Had Key Role In Plummeting Cardiovascular Disease Deaths In Past Decade, British Medical Journal Reveals

Lashing Out At Wife? Check Your Glucose Level, Ohio State University Study

FDA Approves GlaxoSmithKline's Tanzeum To Treat Type 2 Diabetes

We???re Over The Hill At 24, Simon Fraser University Study

Johnson & Johnson Halts Development Of Botox Rival, Axes Staffers

FDA Approves Merck & Co., Inc.'s Grass Pollen Pill GRASTEK®

Organ Recovery Biotech Angion Biomedica Corp. Files For A $35 Million IPO

Women Are More Vulnerable To Alzheimer's Gene, Stanford University School of Medicine Study

Benitec Biopharma Wraps Up $29 Million+ Funding Round

Roche's Q1 Saved By Cancer Drugs Perjeta And Kadcyla

AbbVie's Experimental Hepatitis C Regimen Associated With High Cure Rates In Late-Stage Studies

Startup Emerges From Stealth Mode With $12 Million In Pocket

"Body Hack" App Shortcuts Jet-Lag Recovery, University of Michigan Study

Pelvic Floor Exercises May Help Lifelong Premature Ejaculation, Study

Young Dads Face Depression Risks, Northwestern University Feinberg School of Medicine Study

Hormone Seems To Connect Depression, Memory Loss, Study

Laboratory-Grown Vaginas Implanted In Patients, Wake Forest University Baptist Medical Center Study

Zero-Calorie Fat Substitute In Chips May Remove Toxins From Body, University of Cincinnati Study

New Direction For Drugmakers Such As Merck & Co., Inc., Sanofi (France): Seeking Cure For Deadly Bowel Infection

Johnson & Johnson Innovation Center Joins The Scripps Research Institute Advance Drug Discovery Effort

New Jersey's Elite Pharmaceuticals, Inc. Bags $40 Million

Men, Women In More Satisfying Relationships Have Lower Testosterone, University of Michigan Study

Sun Pharmaceutical Industries Ltd, Ranbaxy Laboratories Merger Equals Generic Powerhouse: Layoffs Projected To Save $250 Million In Costs

Saga Continues: Roche's Tamiflu No Better Than Tylenol At "Fighting Flu"

Low Vitamin D Linked To Fatty Liver Disease In UK Children, And University of Surrey Study

Staying Slim During Pregnancy Linked To Child's Obesity, Kaiser Permanente Study

Gut Microbiota Linked To Alcoholic Liver Disease, Reveals

GlaxoSmithKline Can't Catch A Break, Faces Bribery Allegations In Poland

Science Says There's No Point To Faking Orgasms, Study

Cytos Biotechnology AG's Asthma Drug CYT003 Flunks Pivotal Phase 2b Study

Overeating Can Lead To Brown Fat "Dysfunction," Boston University Study

Taking Iron Improves Women's Exercise Performance, University of Melbourne Study

Alimera Sciences Announces New PDUFA Date For ILUVIEN®

Intercept Pharmaceuticals Reports Additional Positive Data From POISE Trial At Late-Breaker Session

Aerobic Exercise May Boost Older Women's Brain, /i> Reveals

Want A Muscular Body? Eat More Green Tomatoes, Harvard University And Massachusetts Institute of Technology (MIT) Study

Roche, Novartis AG Offices Raided Over Wet AMD Treatments

Merck & Co., Inc. Wants To Test Zilmax On 240,000 Cattle But Beef Industry Resists

Acura Pharmaceuticals, Inc. Walks Away From Pfizer Inc. Licensing Pact

Doctors Welcome Hepatitis C Drug Rivals, Gilead Sciences, Inc. Still Leads

Big Pharmas Prescribe Lucrative Management Careers For MBAs

Spinifex Pharmaceuticals Bags $45 Million To Fund Pain Drug Trials, Established U.S. Base In Connecticut

Massachusetts Reveals 2020 Vision; Who's Cutting Jobs? Who's Hiring?

NuCana Hauls In $57 Million

Meet Your Unborn Child—Before It's Even Conceived, Princeton University Study

Antidepressants And Breastfeeding Can Mix, University of Adelaide Study

Novartis AG To Sell Off Land For Homes While Exploring Options For Future Science Or Business Park

Bay Area's IMPAX Laboratories, Inc. Tries Again With Once-Rebuffed Parkinson's Drug Rytary

Cognitive Decline May Decrease Risk Of Cancer Mortality, Study

FDA Orders Halozyme Therapeutics, Inc. To Halt Pancreatic Cancer Study

Bio-Rad Laboratories, Inc. Scoops Up Cambridge-Based GnuBIO, Inc For Undisclosed Amount

Beware Gilead Sciences, Inc., Merck & Co., Inc.'s Hepatitis C Combo Pill Impresses In Phase 2 Trial

Pfizer Inc. CEO Takes On Additional Role, Becomes PhRMA Board Chairman

Bristol-Myers Squibb Company's Hepatitis C Drug Cures Up To 90 Percent In Phase 3 Study

San Diego's Celladon Corporation Grabs FDA's ???Breakthrough Therapy??? Status for Gene Therapy

Popular Painkillers Linked To Irregular Hearbeat, Erasmus University Medical Center Study

Revealed: Chinese People Have Faster Eye Responses, University of Liverpool Study

Does Pop Music Increase Teen's Alcoholism Risk? University of Pittsburgh Study

Drinking Milk Tied to Arthritis Relief, Brigham and Women's Hospital Study

Link Between Viagra And Melanoma Discovered, JAMA Reveals

Is Homeopathy Bogus Or Is The Newest Report That Says It Is Another Example Of Junk Science? Reveals

Recruitment Begins For 100 Eli Lilly and Company Jobs

Chromium Supplements May Not Lower Blood Sugar Levels, University of Miami Study

Connection Between Integrity Of Brain's White Matter, Cognitive Health, University of Kentucky Study

Emeryville's Adamas Pharmaceuticals IPO Prices At $16, Low End Of Range

Northwest Biotherapeutics Scrounges Up $32 Million

Seattle's Juno Therapeutics Pauses Trial After Patient Deaths

222


    Read more..